ANWPX
Price
$75.26
Change
+$0.22 (+0.29%)
Updated
Sep 11 closing price
Net Assets
169.01B
JDWNX
Price
$133.77
Change
-$1.33 (-0.98%)
Updated
Sep 10 closing price
Net Assets
4.77B
Interact to see
Advertisement

ANWPX vs JDWNX

ANWPX vs JDWNX Comparison Chart in %
View a ticker or compare two or three
VS
ANWPX vs. JDWNX commentary
Sep 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANWPX is a StrongBuy and JDWNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ANWPX has more cash in the bank: 169B vs. JDWNX (4.77B). ANWPX pays higher dividends than JDWNX: ANWPX (0.96) vs JDWNX (0.55). ANWPX was incepted earlier than JDWNX: ANWPX (54 years) vs JDWNX (9 years). JDWNX (0.75) is less costly to investors than ANWPX (0.71). JDWNX is a more actively managed with annual turnover of: 33.00 vs. ANWPX (23.00). ANWPX has a lower initial minimum investment than JDWNX: ANWPX (250) vs JDWNX (1000000). JDWNX annual gain was more profitable for investors over the last year : 5.10 vs. ANWPX (4.04). JDWNX return over 5 years is better than : 23.29 vs. ANWPX (11.02).
ANWPXJDWNXANWPX / JDWNX
Total Expense Ratio0.710.7595%
Annual Report Gross Expense Ratio0.710.7595%
Fund Existence54 years9 years-
Gain YTD6.58510.35364%
Front Load6%N/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets169B4.77B3,541%
Annual Yield % from dividends0.960.55174%
Returns for 1 year4.045.1079%
Returns for 3 years40.1248.3383%
Returns for 5 years11.0223.2947%
Returns for 10 years111.25N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ERSGX12.870.12
+0.94%
Eaton Vance Small-Cap R
PJIZX11.250.09
+0.81%
PGIM Quant Solutions International Eq Z
RGESX12.510.10
+0.81%
Russell Inv Global Equity S
SPMGX9.970.01
+0.10%
Invesco SteelPath MLP Alpha R
FOTGX26.02-3.88
-12.98%
Fidelity Advisor OTC C